AMCR Stock Analysis: Amcor | NYSE

Flexible Packaging, Rigid Containers, Closures, Dispensing Devices

Total Rating 30

Safety 28

Buy Signal -0.18

Packaging & Containers
Industry Rotation: +0.8

Market Cap: 21.4B
Avg Turnover: 175M

Risk 3d forecast

Volatility25.4%

VaR 5^th Pctl4.15%

VaR vs Median-0.94%

Reward TTM

Sharpe Ratio0.37

Rel. Str. IBD50.6

Rel. Str. Peer Group57.5

Character TTM

Beta0.443

Beta Downside0.329

Hurst Exponent0.501

Drawdowns 3y

Max DD29.90%

CAGR/Max DD0.14

CAGR/Mean DD0.37

EPS (Earnings per Share)

EPS CAGR: -6.17%
EPS Trend: -70.6%

Last SUE: 1.16
Qual. Beats: 1

Revenue

Rev. CAGR: 21.71%
Rev. Trend: 82.4%

Last SUE: 1.97
Qual. Beats: 3

Warnings

Strong Share Dilution

High Debt While Negative Cash Flow

Beneish M-Score Likely Earnings Manipulation

Altman Z'' In Financial Distress Zone

Below Avwap Earnings

Tailwinds

Garp

Seasonality 11.6 years of data

Jan -0.6% 2

Feb +0.1% 5

Mar +0.4% 5

Apr -0.1% 10

May +1.2% 20

Jun +0.6% 17

Jul +1.4% 24

Aug -1.1% 2

Sep -1.3% 52

Oct -1.1% 12

Nov +6.3% 17

Dec +0.6% 0

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: AMCR Amcor

Amcor PLC is a global packaging manufacturer headquartered in Zurich, Switzerland, operating across Europe, North America, Latin America, and Asia Pacific. The company runs two main segments: Global Flexible Packaging Solutions, which produces polymer resin, aluminum, and fiber-based flexible packaging for food and beverage, medical and pharmaceutical, fresh produce, snack food, and personal care industries; and Global Rigid Packaging Solutions, which manufactures rigid containers, closures, dispensing systems, and pharmaceutical devices primarily for food and beverage applications.

Founded in 1926 and listed on the NYSE in 2019, Amcor sells its products primarily through a direct sales force. The packaging industry in which it operates is generally considered defensive, with demand closely tied to consumer staples and healthcare end markets rather than discretionary spending cycles.

Amcor is classified within the GICS Materials sector under the Metal, Glass & Plastic Containers sub-industry, reflecting its core focus on producing container and packaging components rather than raw materials extraction. As a large-cap issuer, it serves as one of the more established publicly traded packaging companies globally, supplying both consumer goods manufacturers and pharmaceutical companies.

Headlines to Watch Out For

Berry Global merger integration drives cost synergies and revenue scale
Resin and aluminum cost volatility pressures packaging segment margins
EU sustainability regulation accelerates demand for recyclable flexible packaging

Piotroski VR-10 (Strict) 3.5

Net Income: 1.21b TTM > 0 and > 6% of Revenue
FCF/TA: -16.2k > 0.02 and ΔFCF/TA -1.62m > 1.0
NWC/Revenue: -28.42% < 20% (prev 9.64%; Δ -38.06% < -1%)
CFO/TA -7.95k > 3% & CFO -295.0m > Net Income 1.21b
Net Debt (16.1b) to EBITDA (3.49b): 4.60 < 3
Current Ratio: 0.00 > 1.5 & < 3
Outstanding Shares: last quarter (463.8m) vs 12m ago 45.57% < -2%
Gross Margin: 20.80% > 18% (prev 18.88%; Δ 1.91% > 0.5%)
Asset Turnover: 129.3% > 50% (prev 40.49%; Δ 88.85% > 0%)
Interest Coverage Ratio: 3.32 > 6 (EBIT TTM 2.01b / Interest Expense TTM 606.0m)

Altman Z'' -15.00

A: -184k (Total Current Assets 8.43k - Total Current Liabilities 6.81b) / Total Assets 37.1k
B: 10.0k (Retained Earnings 371.0m / Total Assets 37.1k)
C: 0.11 (EBIT TTM 2.01b / Avg Total Assets 18.5b)
D: 0.00 (Book Value of Equity 37.1k / Total Liabilities 25.9b)
Altman-Z'' = -1.17m = D

Beneish M 1.00

DSRI: 0.10 (Receivables 3.64k/3.43b, Revenue 24.0b/15.0b)
GMI: 0.91 (GM 18.88% / 20.80%)
AQI: 1.10 (AQ_t 0.57 / AQ_t-1 0.52)
SGI: 1.60 (Revenue 24.0b / 15.0b)
TATA: 40.5k (NI 1.21b - CFO -295.0m) / TA 37.1k)
Beneish M = 4.33k (Cap -4..+1) = D

What is the price of AMCR shares?

As of August 16, 2026, the stock is trading at USD 46.03 with a total of 2,350,507 shares traded. Over the past week, the price has changed by -3.82%, over one month by +7.60%, over three months by +21.27% and over the past year by +11.61%.

Current recommended Stop Loss: 44.00 (which is 4.4% or 1.6 ATR below the current price).

Is AMCR a buy, sell or hold?

Amcor has received a consensus analysts rating of 3.90. Therefore, it is recommended to buy AMCR.

StrongBuy: 3
Buy: 3
Hold: 4
Sell: 0
StrongSell: 0

What are the forecasts/targets for the AMCR price?

Analysts Target Price	49	6.4%

Amcor (AMCR) - Fundamental Data Overview as of 15 August 2026

Market Cap USD = 21.4b (21.4b USD * 1.0 USD.USD)
P/E Trailing = 19.5696
P/E Forward = 11.6009
P/S = 0.9123
P/B = 1.8695
P/EG = 0.6411
Revenue TTM = 24.0b USD
EBIT TTM = 2.01b USD
EBITDA TTM = 3.49b USD
Long Term Debt = 15.2b USD (from longTermDebt, two quarters ago)
Short Term Debt = 150.0 USD (from shortTermDebt, last quarter)
Debt = 16.1b USD (corrected: LT Debt 15.2b + ST Debt 150.0) + Leases 853.0m
Net Debt = 16.1b USD (calculated: Debt 16.1b - CCE 1.11k)
Enterprise Value = 37.5b USD (21.4b + Debt 16.1b - CCE 1.11k)
Interest Coverage Ratio = 3.32 (Ebit TTM 2.01b / Interest Expense TTM 606.0m)
EV/FCF = -62.27x (Enterprise Value 37.5b / FCF TTM -602.2m)
FCF Yield = -1.61% (FCF TTM -602.2m / Enterprise Value 37.5b)
FCF Margin = -2.51% (FCF TTM -602.2m / Revenue TTM 24.0b)
Net Margin = 5.04% (Net Income TTM 1.21b / Revenue TTM 24.0b)
Gross Margin = 20.80% ((Revenue TTM 24.0b - Cost of Revenue TTM 19.0b) / Revenue TTM)
Gross Margin QoQ = 25.24% (prev 20.12%)
Tobins Q-Ratio = 1.01m (set to none) (Enterprise Value 37.5b / Total Assets 37.1k)
Interest Expense / Debt = 3.77% (Interest Expense 606.0m / Debt 16.1b)
Taxrate = 20.17% (97.0m / 481.0m)
NOPAT = 1.61b (EBIT 2.01b * (1 - 20.17%))
Current Ratio = 0.00 (Total Current Assets 8.43k / Total Current Liabilities 6.81b)
Debt / Equity = 433k (out of range, set to none) (Debt 16.1b / totalStockholderEquity, last quarter 37.1k)
Debt / EBITDA = 4.60 (Net Debt 16.1b / EBITDA 3.49b)
Debt / FCF = -26.66 (negative FCF - burning cash) (Net Debt 16.1b / FCF TTM -602.2m)
Total Stockholder Equity = 8.76b (last 4 quarters mean from totalStockholderEquity)
RoA = 6.51% (Net Income 1.21b / Total Assets 37.1k)
RoE = 13.79% (Net Income TTM 1.21b / Total Stockholder Equity 8.76b)
RoCE = 8.40% (EBIT 2.01b / Capital Employed (Equity 8.76b + L.T.Debt 15.2b))
RoIC = 4.46m% (out of range, set to none) (NOPAT 1.61b / Invested Capital 36.0k)
WACC = 5.60% (E(21.4b)/V(37.5b) * Re(7.54%) + D(16.1b)/V(37.5b) * Rd(3.77%) * (1-Tc(0.20)))
Discount Rate = 7.54% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 88.07 | Cagr: 23.59%
[DCF] Fair Price = unknown (Cash Flow -602.2m)
EPS Correlation: -70.56 | EPS CAGR: -6.17% | SUE: 1.16 | # QB: 1
Revenue Correlation: 82.44 | Revenue CAGR: 21.71% | SUE: 1.97 | # QB: 3
EPS current Quarter (2026-09-30): EPS=1.04 | Chg30d=+0.39% | Revisions=-17% | Analysts=9
EPS next Quarter (2026-12-31): EPS=0.90 | Chg30d=-1.10% | Revisions=-50% | Analysts=9
EPS current Year (2027-06-30): EPS=4.28 | Chg30d=-0.23% | Revisions=-50% | GrowthEPS=+6.4% | GrowthRev=+1.0%
EPS next Year (2028-06-30): EPS=4.61 | Chg30d=-0.22% | Revisions=-40% | GrowthEPS=+7.7% | GrowthRev=+0.7%
[Analyst] Revisions Ratio: -64% (up=1, down=10)